Medicure (OTCMKTS:MCUJF) Share Price Passes Above 50-Day Moving Average – Should You Sell?

Medicure Inc. (OTCMKTS:MCUJF)’s stock price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.75 and traded as high as $0.8081. Medicure shares last traded at $0.8081, with a volume of 200 shares changing hands.

Medicure Price Performance

The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.03. The stock has a fifty day simple moving average of $0.75 and a 200-day simple moving average of $0.81. The stock has a market cap of $8.44 million, a price-to-earnings ratio of -1.72 and a beta of 1.02.

Medicure (OTCMKTS:MCUJF) last posted its quarterly earnings data on Thursday, May 21st. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.01. The company had revenue of $5.79 million during the quarter, compared to analysts’ expectations of $3.63 million. Medicure had a negative return on equity of 44.34% and a negative net margin of 21.65%.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.